PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 234 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $164,789 | -81.0% | 112,869 | 0.0% | 0.00% | – |
| Q4 2023 | $866,834 | -32.1% | 112,869 | -29.4% | 0.00% | -100.0% |
| Q3 2023 | $1,276,441 | -0.6% | 159,955 | +60.6% | 0.00% | 0.0% |
| Q2 2023 | $1,283,715 | +32081.4% | 99,590 | +27259.9% | 0.00% | – |
| Q1 2023 | $3,989 | -95.7% | 364 | -96.1% | 0.00% | – |
| Q4 2022 | $92,862 | -21.3% | 9,399 | -48.1% | 0.00% | – |
| Q3 2022 | $118,000 | +40.5% | 18,103 | -0.0% | 0.00% | – |
| Q2 2022 | $84,000 | +2700.0% | 18,108 | +4627.9% | 0.00% | – |
| Q1 2022 | $3,000 | -99.8% | 383 | -99.7% | 0.00% | -100.0% |
| Q4 2021 | $1,508,000 | -77.8% | 114,240 | -57.1% | 0.00% | -80.0% |
| Q3 2021 | $6,806,000 | -56.6% | 266,381 | -40.6% | 0.01% | -54.5% |
| Q2 2021 | $15,670,000 | – | 448,093 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
| Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
| Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
| BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
| ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
| ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
| Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
| Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |